GSDMD and non-small cell lung carcinoma: NLRP3 inflammasome-mediated pyroptosis promotes the progression of lung adenocarcinoma but inhibits the progression of non-small-cell lung cancer, while GSDMD-mediated pyroptosis promotes the progression of non-small-cell lung cancer [28].